The Growing Trend of Diagnosing and Treating Chronic Diseases in Convenient Care Clinics
This activity is intended for advanced practice nurses including Nurse Practitioners and Physician Assistants
Kristene Diggins FAANP, DNP, MBA, DCC, CNE, NEA-BC
Manager professional practice
CVS Caremark-Minute Clinic
Yvette C. Terrie, BSPharm, RPh
Upon completion of this activity, the participant should be able to:
Statement of Need
Outline the factors contributing to the rapid growth of convenient care clinics.
Identify effective clinical practices associated with the treatment, prevention, and management of chronic diseases in convenient care clinics.
Illustrate the impact of collaborative efforts between nurse practitioners, physician assistants, and other health care professionals in disease management.
Explain the significance of patient education and continual care in the management and prevention of chronic disease.
Evidence has shown that nurse practitioners and physician assistants have a positive impact on the therapeutic outcomes in patients with chronic diseases. Both nurse practitioners and physician assistants in convenient care clinics play an important role in identifying patients at risk for chronic disease, providing routine assessments of patients, changing the treatment plan when warranted and providing patient education. This educational activity has been developed to support nurse practitioners and physician assistants in providing continuity of care, individualized treatment strategies and patient education for those with chronic conditions.
Jointly provided by Dannemiller and Pharmacy Times Office of Continuing Professional Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Dannemiller and Pharmacy Times. Dannemiller is accredited by the ACCME to provide continuing medical education for physicians.
Dannemiller designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)
TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s) TM from organizations accredited by ACCME.
Dannemiller is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 090419.
This program is accredited for 1.0 contact hour(s) which includes 0.0 hour(s) of pharmacology.
Method of Participation
To receive credit, all participants will need to read the objectives and other introductory CME/CE information, take the pretest and then proceed to the educational activity. Once the activity is completed along with the posttest and the evaluation, participants can request credit.
You will have access to your certificate immediately following completion of the evaluation. Credit is provided through 8/4/2016. No credit will be given after this date. There is no fee to participate in this activity.
In the event you have questions about this activity or are unable to retrieve the certificate, please e-mail email@example.com and a certificate will be emailed within 2 weeks.
System Requirements for Completion of Post-Test and Evaluation
Computer or smart phone with internet access
Kristene Diggins, FAANP, CNE, NEA-BC, DNP, DCC, MBA
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), Dannemiller requires that any person who is in a position to control the content of a CME/CE activity must disclose all financial relationships they have with a commercial interest.
The following individuals, who are associated with the planning and execution of this activity, have stated they have no financial relationships with commercial interests: Dave Heckard (Pharmacy Times), Yvette Terrie (Pharmacy Times), Jim Palatine (Pharmacy Times), Erin Fletcher (Dannemiller), Kristene Diggins (Faculty).
To resolve identified/potential conflicts of interest, the educational content was fully reviewed by a member of the Dannemiller Clinical Content Review Committee, Gloria Herrera, who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence based and commercially balanced.
Off label statement provided: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Dannemiller or Pharmacy Times Office of Continuing Professional Education. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject